Nektar Therapeutics Surges After Positive Eczema Drug Trial Results
Shares double as midstage study shows promising efficacy and safety for autoimmune treatment Nektar Therapeutics (NKTR) saw its shares double ...
Shares double as midstage study shows promising efficacy and safety for autoimmune treatment Nektar Therapeutics (NKTR) saw its shares double ...
Analysts highlight best ideas for 2025 with bullish calls on growth, innovation, and market resilience Wall Street analysts are rolling ...
Robust travel demand and onboard spending push Carnival Corp to raise full-year profit outlook Carnival Corp (CCL) raised its annual ...
NHTSA investigates safety of self-driving deployment in Texas, but Tesla withholds answers as proprietary information Tesla (TSLA) is keeping its ...
Grocery giant raises same-store sales outlook while navigating leadership uncertainty and a tough retail landscape Kroger (KR) stock jumped 9% ...
CEO Lip-Bu Tan accelerates leadership overhaul with key executive appointments amid turnaround push Intel (INTC) has made a bold move ...
Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on ...
Strong execution, AI momentum, and expanding market share fuel bullish outlook Advanced Micro Devices (AMD) is quickly cementing its position ...
Michael Saylor’s crypto-driven “volatility engine” continues to fuel investor intrigue—and debate—as rivals struggle to match Strategy’s results Strategy (MSTR), the ...
Luke Lloyd says falling rates and AI's energy demands set the stage for long-duration Treasuries and utilities to outperform As ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?